Atkore (ATKR) director adds 94 dividend units to RSU-based stake
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Atkore Inc. director Justin A. Kershaw reported an automatic share-based accrual rather than an open-market trade. He acquired 94.4194 shares of common stock at a price of $0.00 per share, representing dividend equivalent units accrued on unvested or deferred restricted stock units. Following this grant, his directly held common stock position, including unvested or deferred RSUs and related dividend equivalent units, totals 21,408.7243 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Kershaw Justin A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 94.419 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 21,408.724 shares (Direct)
Footnotes (1)
- Represents dividend equivalent units accrued on unvested or deferred restricted stock units ("RSUs"). Includes unvested or deferred restricted stock units ("RSUs") and amounts accrued for dividend equivalent units on such RSUs.
FAQ
What insider transaction did Atkore (ATKR) director Justin Kershaw report?
Atkore director Justin A. Kershaw reported acquiring 94.4194 shares of common stock at $0.00 per share. The filing describes these as dividend equivalent units credited on unvested or deferred restricted stock units rather than an open-market stock purchase.
What are dividend equivalent units in Atkore (ATKR) director equity awards?
Dividend equivalent units are additional share-based credits tied to dividends on unvested or deferred RSUs. In Justin Kershaw’s case, 94.4194 such units accrued on his Atkore RSUs, increasing his reported common stock holdings without a cash transaction, according to the Form 4 footnotes.
Is Justin Kershaw’s Atkore (ATKR) Form 4 transaction a buy or a grant?
The filing records it as a grant-type acquisition rather than a market buy. The transaction code “A” and description indicate a grant, award, or other acquisition, specifically dividend equivalent units accruing on unvested or deferred RSUs, at a stated price of $0.00 per share.